[et_pb_section fb_built=”1″ admin_label=”!!! PLEASE DO NOT EDIT !!!” _builder_version=”4.16″ global_colors_info=”{}”][et_pb_row admin_label=”!!! PLEASE DO NOT EDIT !!!” _builder_version=”4.16″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text admin_label=”TO BE EDITED – TEXT – Click on the WHEEL icon to open the text-area where you can type your text. Add a paragraph to introduce the Document” _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n
A new report by R-Health Consult, commissioned the European Federation of Pharmaceutical Industries and Associations (EFPIA), highlights the significant health and economic benefits of investing in the prevention, early detection, and treatment of five major non-communicable diseases (NCDs) in the EU: stroke, ischaemic heart disease, type 2 diabetes, COPD, and breast cancer. In 2023, these diseases cost the EU approximately \u20ac530 billion\u2014over 3% of its GDP\u2014mainly due to direct healthcare costs.<\/p>\n
With cases projected to rise by 16% by 2050, the report underscores the urgency of targeted action.\u00a0Using case studies from Portugal, Romania, and Sweden, the report demonstrates how strategic, value-based health investments can improve patient outcomes and deliver substantial returns. It offers actionable insights for EU policymakers, particularly within health and finance ministries, on how to strengthen national health systems. The findings make a compelling case that improving health is not just a moral imperative, but a smart economic strategy for the EU\u2019s future.<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"
A new report by R-Health Consult, commissioned the European Federation of Pharmaceutical Industries and Associations (EFPIA), highlights the significant health and economic benefits of investing in the prevention, early detection, and treatment of five major non-communicable diseases (NCDs) in the EU: stroke, ischaemic heart disease, type 2 diabetes, COPD, and breast cancer. In 2023, these…<\/p>\n","protected":false},"author":559,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":""},"categories":[],"tags":[3048,3024,3046],"document_type":[2336],"acf":[],"_links":{"self":[{"href":"https:\/\/p4h.world\/en\/wp-json\/wp\/v2\/documents\/987767723"}],"collection":[{"href":"https:\/\/p4h.world\/en\/wp-json\/wp\/v2\/documents"}],"about":[{"href":"https:\/\/p4h.world\/en\/wp-json\/wp\/v2\/types\/documents"}],"author":[{"embeddable":true,"href":"https:\/\/p4h.world\/en\/wp-json\/wp\/v2\/users\/559"}],"replies":[{"embeddable":true,"href":"https:\/\/p4h.world\/en\/wp-json\/wp\/v2\/comments?post=987767723"}],"version-history":[{"count":4,"href":"https:\/\/p4h.world\/en\/wp-json\/wp\/v2\/documents\/987767723\/revisions"}],"predecessor-version":[{"id":987767736,"href":"https:\/\/p4h.world\/en\/wp-json\/wp\/v2\/documents\/987767723\/revisions\/987767736"}],"wp:attachment":[{"href":"https:\/\/p4h.world\/en\/wp-json\/wp\/v2\/media?parent=987767723"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/p4h.world\/en\/wp-json\/wp\/v2\/categories?post=987767723"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/p4h.world\/en\/wp-json\/wp\/v2\/tags?post=987767723"},{"taxonomy":"document_type","embeddable":true,"href":"https:\/\/p4h.world\/en\/wp-json\/wp\/v2\/document_type?post=987767723"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}